Driving Innovation in Drug R&D

Today pharma innovation is advancing at an incredible pace, with opportunities to address diseases once considered intractable using advanced technologies. At the Second Annual World Pharma Week we will bring together, technical leaders, scientists, and executives, visionaries, and biotech entrepreneurs to drive measurable innovation in biopharma R&D.

Learn More »



Past Speakers

Jennifer Michaelson, PhD
Vice President, Preclinical Research & Early Development, Cullinan Oncology

Litao Zhang, PhD
Vice President, Leads Discovery and Optimization, Bristol-Myers

Michael Woo
Director, Head of Immuno-Oncology Search & Evaluation, External Innovation, EMD Serono, Inc

Leigh Zawel, PhD
CSO, Cullinan Oncology; Executive Partner, MPM Capital


Emma Lees, PhD
Vice President and Oncology Site Head, Bristol-Myers Squibb

Laszlo Urban, MD, PhD
Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for Biomedical Research

Holly D. Soares, PhD
Head, Translational Neuroscience, AbbVie

Stephen Fawell, PhD
Vice President, Head Oncology Discovery, AstraZeneca


Attention Pharma!

If you are an employee of the following TOP 25 Pharmaceutical Companies as cited by Pharmaceutical Executive* you may attend this meeting at a 25% discount off the current rate. Enter Keycode PH25 upon checkout when registering World Pharma Week on-line.

Group registrations are encouraged and we suggest calling:

Jeffrey Knight
Account Manager, Cambridge Healthtech Institute
T: 781-247-6264 | E: jknight@healthtech.com